Furthermore, Lelliott et al. applied scRNA-seq and CITE-seq in an ovarian cancer mouse model demonstrating that CDK4/6i might enhance the cytotoxic effects CAR-T-cells, thereby improving the effectiveness and persistence of tumor control [189]. This evidence concerns the gene CDK4 and ovarian cancer.